Clinical Trials at Willamette Valley Cancer Institute and Research Center
As of August 2026, 13 paid clinical trials are recruiting at Willamette Valley Cancer Institute and Research Center in Eugene, Oregon. Active studies at this site cover conditions such as Endometrial Cancer, Multiple Myeloma and Chronic Lymphocytic Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
13 clinical trials at Willamette Valley Cancer Institute and Research Center
·Clear filters·A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
MYLUNG Consortium Part 3: Observational Study
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Common conditions studied in Eugene
- Endometrial Cancer (8 active studies)
- Multiple Myeloma (6 active studies)
- Chronic Lymphocytic Leukemia (5 active studies)
- Fallopian Tube Cancer (4 active studies)
- Ovarian Cancer (4 active studies)
- Breast Cancer (3 active studies)
Leading research sponsors in Eugene
- University of Oregon
- AbbVie
- Pfizer
- Eli Lilly and Company
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Eugene?
There are approximately 129 recruiting clinical trials in Eugene, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Eugene pay participants?
Most recruiting trials in Eugene compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Eugene?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Eugene?
The most common conditions under active study in Eugene include Endometrial Cancer (8), Multiple Myeloma (6), Chronic Lymphocytic Leukemia (5), Fallopian Tube Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Eugene?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Eugene on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Eugene?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Eugene?
Recruiting research sites in Eugene include Willamette Valley Cancer Institute and Research Center, Oncology Associates of Oregon, P.C., University of Oregon, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Eugene right now?
The largest active categories in Eugene are Cancer & tumors (61), Eye & vision (10), Mental health & behavior (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.